Inspire Medical系統 INSP 深 滬
等待開盤 03-26 09:30:00 美东时间
51.41
-0.660
-1.27%
華盛通- 最 高52.98
- 今 開52.63
- 成交量 75.45万股
- 最 低 50.555
- 昨 收 52.07
- 總市值 14.70亿
- 52周最高 163.35
- 市盈率 靜 10.52
- 換手率 2.64%
- 52周最低 50.50
- 委 比 0.00%
- 總股本 2858.93万
- 歷史最高 330.00
- 量 比 0.74
- 振 幅 4.66%
- 歷史最低 22.50
- 每 手 1
- 風險率 32.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top 3 Health Care Stocks That Are Set To Fly In March
Opportunity to buy undervalued health care stocks. RSI is a momentum indicator that compares strength on up and down days. Here's a list of oversold stocks with RSI near or below 30.
03-20 18:23
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
Inspire Medical Systems shares are trading higher after a KeyBanc note indicated that CMS appears ready to add INSP V Specific C-Codes in April 2026 IOCE update
Inspire Medical Systems shares are trading higher after a KeyBanc note indicate...
02-27 03:43
美股大行评级 | AppLovin评级分歧大！高盛等4家下调，韦德布什上调；HubSpot、休曼纳公司、Shopify、Unity、Paycom Software等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从39美元升至47美元；HC Wainwright & Co.：维持Agios制药"买入"评级，目标价从62美元升至65美元
02-13 15:30
电话会总结 ｜ Inspire Medical(INSP)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Inspire Medical业绩会实录，以下是2025年财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 第四季度营收2.69亿美元，同比增长12% - 全年营收9.12亿美元，同比增长14% - 美国市场全年营收8.072亿美元，海外市场营收3,990万美元 - 第四季度美国营收2.569亿美元，海外营收1,210万美元 **盈利能力：** - 第四季度每股净收益4.66美元，同比增长3.51美元 - 全年每股净收益4.89美元，同比增长3.09美元 - 第四季度调整后每股净收益1.65美元，同比增长0.51美元 - 全年调整
02-12 12:27
Inspire Medical Systems shares are trading lower after the company reported Q4 financial results and issued FY26 sales guidance with its midpoint below estimates.
Inspire Medical Systems shares are trading lower after the company reported Q4 ...
02-12 05:25
Inspire Medical Systems Sees FY2026 GAAP EPS $1.23-$1.81 vs $1.68 Est
Inspire Medical Systems (NYSE:INSP) is looking for FY2026 GAAP EPS of $1.23-$1.81 vs $1.68 analyst estimate..
02-12 05:13
Inspire Medical Systems Q4 Adj. EPS $1.65 Beats $0.88 Estimate, Sales $269.077M Beat $265.666M Estimate
Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $1.65 per share which beat the analyst consensus estimate of $0.88 by 88.57 percent. This is a 43.48 percent increase over earnings of $1.15 per share
02-12 05:03
Earnings Scheduled For February 11, 2026
Companies Reporting Before The Bell • SiteOne Landscape Supply (NYSE:SITE) is p...
02-11 19:11
Preview: Inspire Medical Systems's Earnings
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earning...
02-11 03:02
